pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NOVARTIS · news · pharmadog
← back to NOVARTIS
News mentioning NOVARTIS
367
stories
Jul 20, 26
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
biospace
Jul 20, 26
Scribe aims for $96M IPO to fund clinical push for lipid-lowering genetic meds
fiercebiotech
Jul 17, 26
Jasper gets a lifeline in merger with immune drugmaker Kira
biopharma dive
Jul 17, 26
Dimerix buys a kidney injury drug; Arpeggio appears to be winding down
endpoints
Jul 17, 26
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances
biopharma dive
Jul 17, 26
Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador
fiercebiotech
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 14, 26
Celcuity wins approval for breast cancer drug Revtorpyk
endpoints
Jul 13, 26
STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
stat
Jul 10, 26
STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
stat
Jul 9, 26
STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and more
stat
Jul 8, 26
Novartis cuts New Jersey jobs; OTR, LG Chem explore China cancer drugs
endpoints
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 7, 26
Novartis, Vertex and Ipsen extend pharma M&A spree from 2026's first half
endpoints
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
Jul 7, 26
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
Jul 6, 26
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
stat
Jul 6, 26
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
Jul 6, 26
STAT+: Four major biotech updates to catch up on
stat
Jul 6, 26
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
stat
Jul 6, 26
Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platform
endpoints
Jul 2, 26
Sandoz launches direct-to-consumer platform with growth disorder drug
endpoints
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 17, 26
A new Westlake-backed biotech takes aim at migraines
biopharma dive
Jun 15, 26
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
stat
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
Jun 15, 26
STAT+: Lilly’s Ajax acquisition may have been worth it
stat
Jun 12, 26
STAT+: Prometheus raises $12 billion in capital for artificial engineers
stat
← prev
page 11 of 13
next →
